[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
::
Impact Factor 2022: 1.4
Cite Score 2022: 2.1
SJR 2022: 0.347
SNIP 2022: 0.545
..
Publication Charge
►Publication Fee
..
In Press
 In Press Articles
..
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 11, Issue 3 (5-2020) ::
Caspian J Intern Med 2020, 11(3): 324-328 Back to browse issues page
Association between prostate specific antigen change over time and prostate cancer recurrence risk: a joint model
Reza Ali Mohammadpour , Ahad Alizadeh , Mohammadreza Barzegartahamtan , Abazar Akbarzadeh Pasha
Department of Biostatistics, Faculty of Health, Health Sciences Research Center, Mazandaran University of Medical Sciences, Sari, Iran , Mohammadpour2002@yahoo.com
Abstract:   (3462 Views)
Background: Prostate specific antigen (PSA) is an important biomarker to monitor patients after treated with radiation therapy (RT). The aim of this study is to evaluate the relationship between the PSA data and prostate cancer recurrence using the joint modeling.
Methods: This historical cohort study was performed on 422 prostate cancer patients. Inclusion criteria included: patients with localized prostate cancer referring to Cancer Institute in Tehran (Iran) from 2007 to 2012, and under radiation therapy. Joint model has two components or sub-models. We showed the results by parameter estimating the longitudinal sub-model and survival sub-model. EM algorithm, Newton-Gauss and Gauss-Hermit law were used for final model parameters. R software version 3.2 was used for statistical analysis.
Results: In this study, considering the inclusion and exclusion criteria, out of 422 patients, the data on 314 cases were selected for analysis and the main result of joint model was obtained. PSA directly and significantly was associated with recurrence risk, therefore increasing 2.6 ml/lit PSA (one unit in transformed PSA) increases 39% recurrence risk (95% CI for RR: 1.09-1.77). Also, slope of PSA trend has significant association with prostate cancer recurrence risk (95% CI for RR: 1.05-1.41).
Conclusion: This study showed a significant relationship between PSA, and its slope with the recurrence risk by joint model, with regard to the pathological, demographic and clinical features in the Iranian population.
Keywords: Prostate specific antigen (PSA), prostate cancer recurrence, joint modeling
Full-Text [PDF 241 kb]   (816 Downloads)    
Type of Study: Original Article | Subject: Oncology
Received: 2019/02/27 | Accepted: 2020/02/8 | Published: 2020/05/21
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mohammadpour R A, Alizadeh A, Barzegartahamtan M, Akbarzadeh Pasha A. Association between prostate specific antigen change over time and prostate cancer recurrence risk: a joint model. Caspian J Intern Med 2020; 11 (3) :324-328
URL: http://caspjim.com/article-1-1791-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 11, Issue 3 (5-2020) Back to browse issues page
Caspian Journal of Internal Medicine
Persian site map - English site map - Created in 0.05 seconds with 40 queries by YEKTAWEB 4645